Gabapentin for sleep in menopause: bedtime dosing and risks

Gabapentin can help sleep in menopause when night sweats are what wake you. The Menopause Society recommends it for hot flashes and notes that bedtime dosing may suit women with broken sleep, and trials found better sleep quality scores. The sleep benefit is modest and secondary, it is off-label, and it is not a treatment for insomnia alone.

Why gabapentin is taken at night

Gabapentin is approved by the FDA for certain seizures and for nerve pain after shingles. MedlinePlus lists the treatment and prevention of hot flashes among its off-label uses. For a full overview of how it works on hot flashes, the trial results and cost, see gabapentin for hot flashes. This guide focuses on the night.

The Menopause Society’s 2023 nonhormone position statement rates gabapentin as recommended for hot flashes, based on good and consistent evidence. It points out two features that make the evening the natural time to take it: drowsiness is a side effect, and the drug is short-acting. Its conclusion is that bedtime dosing may be a good choice for women whose sleep is disrupted by hot flashes.

The statement’s suggested schedule starts at night:

• Start with 100 to 300 mg at bedtime (100 mg if you are sensitive to medicines).
• Add a second 300 mg at night.
• Then add a separate 300 mg dose in the morning.
• The usual range for hot flashes is 900 to 2,400 mg a day in divided doses.

Some women whose symptoms are mostly at night stop at the bedtime step. That has not been compared with full daytime dosing in a trial, so it is a judgment call to make with your prescriber.

What the sleep studies show

No trial has made sleep the main outcome of gabapentin treatment in women with menopausal insomnia. The evidence comes from secondary outcomes in hot flash trials, one comparison trial in breast cancer survivors and a case series.

Study	Who	Gabapentin dose	Sleep finding
Reanalysis of a placebo-controlled trial (2009)	Menopausal women with hot flashes	300 mg three times a day	Better sleep quality scores at 4 and 12 weeks; better overall sleep score and sleep efficiency at 4 weeks only; no effect on daytime disturbance
Phase 3 placebo-controlled trial (2014)	600 women with 7 or more moderate to severe hot flashes a day	Extended-release, 600 mg morning and 1,200 mg evening	Less sleep interference than placebo at weeks 12 and 24
Comparison with electroacupuncture (2017)	58 breast cancer survivors with daily hot flashes	900 mg a day	Overall sleep score improved 0.8 points over 8 weeks, less than the 2.6 points with electroacupuncture
Case series (2012)	3 women in late premenopause waking at night	Bedtime dose	Fewer night wakings; anecdotal only

In the phase 3 trial, the authors described the evening-weighted extended-release form as a modestly effective nonhormone option for hot flashes. It is a specific formulation, and MedlinePlus warns that extended-release gabapentin products cannot be swapped for other forms.

How strong is this? The direction is consistent: when gabapentin reduces night sweats, women report sleeping better. But the sleep outcomes were secondary and self-reported, the effects were modest, and the electroacupuncture trial suggests gabapentin’s sleep gains in women with hot flashes can be small. None of these studies tested gabapentin for insomnia without night sweats, and it has not been compared head to head with CBT-I.

Side effects at bedtime and the morning after

The Menopause Society lists drowsiness, dizziness and impaired balance or coordination as the main adverse effects, typically worst in the first week, improving in the second and gone by week 4.

The trials put numbers on this:

• In a 197-woman trial of 900 mg a day, women on gabapentin reported more dizziness (18%), unsteadiness (14%) and drowsiness (12%) at week 1 than those on placebo; these returned to baseline by week 4.
• In the 600-woman phase 3 trial, dizziness affected 12.7% on gabapentin versus 3.4% on placebo and sleepiness 6.0% versus 2.7%, and 16.7% versus 11.5% stopped because of side effects. These rates fell after a few weeks.

Practical steps:

• Get up slowly at night. Unsteadiness and night-time bathroom trips are a risky combination. See dizziness in perimenopause.
• Do not drive until you know how it affects you. MedlinePlus warns it can slow thinking and cause loss of coordination.
• Tell your clinician about kidney or lung disease, which MedlinePlus flags before starting.
• Watch your mood. MedlinePlus notes that about 1 in 500 people taking anticonvulsants such as gabapentin in clinical studies became suicidal. Report new or worsening low mood, anxiety or agitation. If you have thoughts of harming yourself, call or text 988.

Other listed side effects include swelling of the legs or feet, weight gain, blurred or double vision and memory problems.

The FDA warning on breathing problems

In December 2019 the FDA warned that serious breathing difficulties may occur in people taking gabapentin or pregabalin who have respiratory risk factors. These include taking opioid pain medicines or other drugs that depress the central nervous system, such as benzodiazepines, and conditions that reduce lung function, such as COPD. Older adults are also at higher risk. The FDA advised clinicians to start at the lowest dose and monitor for sedation and breathing problems when gabapentin is combined with an opioid or other depressant.

This matters at bedtime, when gabapentin may be stacked with a sleeping pill, an anxiety medicine, a pain medicine or a glass of wine. MedlinePlus notes that alcohol adds to gabapentin’s drowsiness. See alcohol in perimenopause.

Call 911 for slowed, shallow or difficult breathing, extreme sleepiness, confusion, bluish lips or fingertips, or if someone cannot be woken.

Misuse potential

Gabapentin was long assumed to carry no abuse risk, but that has changed. A 2021 systematic review of 55 studies found growing evidence that gabapentinoids are misused, often alongside other drugs, and that opioid use disorder is the strongest risk factor. The most concerning finding was harm linked to misuse, including higher hospital use and a greater risk of death from opioid overdose. Its use in combination with opioids is one reason the FDA asked manufacturers to study abuse potential further.

For most women taking it at bedtime for night sweats, this is a reason to use the lowest effective dose, keep it to your own prescription and tell your clinician if you have ever had problems with opioids, sedatives or alcohol.

Stopping and tapering

Do not stop gabapentin suddenly after regular use. MedlinePlus lists withdrawal symptoms such as anxiety, trouble falling or staying asleep, nausea, pain and sweating, and notes that doctors may lower the dose gradually over at least a week. Because insomnia and sweating overlap with menopause symptoms, a rough few nights after a fast stop may not mean the original problem has returned. Plan the taper with your prescriber.

How it fits with other options

If night sweats wake you, gabapentin is one of several choices. The Menopause Society calls hormone therapy the most effective treatment for hot flashes and also recommends cognitive behavioral therapy, certain SSRIs and SNRIs, and fezolinetant. See night sweats, hormone therapy and sleep and the ranked best sleep aids for perimenopause.

If you lie awake even on nights without sweats, the insomnia has its own momentum. The American Academy of Sleep Medicine strongly recommends multicomponent cognitive behavioral therapy for insomnia (CBT-I), and it can be combined with gabapentin. See CBT-I for menopause insomnia.

When to see a clinician

Talk to an ob-gyn or menopause clinician if night sweats wake you most nights, if gabapentin leaves you groggy or unsteady after the first few weeks, or if you want to change your dose or stop. Bring a full list of your medicines, including sleep aids, pain medicines and supplements. A two-week sleep diary noting sweats and wake-ups shows whether it is working.

Seek emergency care by calling 911 for any breathing problems, severe sleepiness, a fall with injury, or swelling of the face, lips or throat. If you have thoughts of harming yourself, call or text 988.